Arcus Biosciences shares Q3 financial results, highlighting pipeline advancements for casdatifan, positioning itself strongly in the pharmaceutical preparations sector.
| Name | Arcus Biosciences, Inc. |
|---|---|
| CIK | 0001724521 |
| Tickers | RCUS |
| Exchanges | NYSE |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 473898435 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (510) 694-6200 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Arcus Biosciences shares Q3 financial results, highlighting pipeline advancements for casdatifan, positioning itself strongly in the pharmaceutical preparations sector.
Arcus Biosciences, Inc. completes a public offering, raising $269.7 million to enhance its financial position and support ongoing projects.
Arcus Biosciences, Inc. has filed a prospectus update, indicating potential fundraising efforts in the pharmaceutical preparations industry.
Arcus Biosciences has filed a prospectus supplement for a common stock offering, aiming to raise capital for its clinical programs in cancer treatment.
Arcus Biosciences reports a preliminary cash balance of $694 million as of September 30, 2026, reflecting its financial health in the pharmaceutical industry.
Arcus Biosciences announces new data from its ARC-20 study on casdatifan, showing promising results for treating clear cell renal cell carcinoma.
609 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-04 | 10-Q | 10-Q | 0001724521-26-000058 | 001-38419 | 261522277 | 34 | 7147498 | 1 | 1 | |
| 2026-11-04 | 8-K | 8-K | 2.02,9.01 | 0001724521-26-000056 | 001-38419 | 261522216 | 34 | 326237 | 1 | 1 |
| 2026-10-23 | 8-K | 8-K | 8.01,9.01 | 0001724521-26-000050 | 001-38419 | 261482331 | 34 | 471352 | 1 | 1 |
| 2026-10-22 | 424B5 | 424B5 | 0001193125-26-428916 | 333-293750 | 261478914 | 33 | 932478 | 1 | 1 | |
| 2026-10-21 | 424B5 | 424B5 | 0001193125-26-427888 | 333-293750 | 261476046 | 33 | 788636 | |||
| 2026-10-21 | 8-K | 8-K | 2.02 | 0001193125-26-427829 | 001-38419 | 261475793 | 34 | 136218 | 1 | 1 |
| 2026-10-20 | 8-K | 8-K | 8.01 | 0001724521-26-000047 | 001-38419 | 261470577 | 34 | 143248 | 1 | 1 |
| 2026-09-28 | CT ORDER | filename1.pdf | 20260928,20260928 | 9999999997-26-001556 | 005-90423 | 261415894 | 34 | 106269 | ||
| 2026-08-24 | 4 | FORM 4 | 0001771961-26-000006 | 8667 | ||||||
| 2026-08-21 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008535 | 001-38419 | 261305219 | 33 | 5398 | |||
| 2026-08-07 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-092737 | 005-90423 | 261254722 | 34 | 167800 | |||
| 2026-08-05 | 10-Q | 10-Q | 0001724521-26-000044 | 001-38419 | 261243620 | 34 | 6891022 | 1 | 1 | |
| 2026-08-05 | 8-K | 8-K | 2.02,9.01 | 0001724521-26-000042 | 001-38419 | 261243477 | 34 | 339106 | 1 | 1 |
| 2026-07-13 | 4 | FORM 4 | 0001422996-26-000006 | 10225 | ||||||
| 2026-07-09 | 144 | xsl144X01/primary_doc.xml | 0001958244-26-000445 | 001-38419 | 261166587 | 33 | 10018 | |||
| 2026-06-24 | 144 | xsl144X01/primary_doc.xml | 0001958244-26-000402 | 001-38419 | 261117079 | 33 | 16123 | |||
| 2026-06-24 | 4 | xslF345X06/form4.xml | 0001610717-26-000294 | 12194 | ||||||
| 2026-06-22 | 144 | xsl144X01/primary_doc.xml | 0001958244-26-000398 | 001-38419 | 261108363 | 33 | 8125 | |||
| 2026-06-12 | 4 | FORM 4 | 0001770252-26-000003 | 7149 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001311210-26-000003 | 7256 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001277503-26-000003 | 9481 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001836662-26-000005 | 7020 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001734422-26-000005 | 7147 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001206977-26-000009 | 8051 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001792164-26-000006 | 7859 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001201617-26-000003 | 7142 | ||||||
| 2026-06-12 | 8-K | 8-K | 5.07 | 0001724521-26-000037 | 001-38419 | 261086797 | 34 | 150846 | 1 | 1 |
| 2026-06-01 | 4 | FORM 4 | 0001771961-26-000004 | 5662 | ||||||
| 2026-06-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005400 | 001-38419 | 261051274 | 33 | 4695 | |||
| 2026-05-12 | 4 | FORM 4 | 0001792164-26-000003 | 5511 | ||||||
| 2026-05-12 | 4 | FORM 4 | 0001653881-26-000005 | 4940 | ||||||
| 2026-05-11 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-033690 | 001-38419 | 26964680 | 33 | 5269 | |||
| 2026-05-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004118 | 001-38419 | 26948484 | 33 | 6019 | |||
| 2026-05-05 | 10-Q | 10-Q | 0001724521-26-000034 | 001-38419 | 26943242 | 34 | 6370781 | 1 | 1 | |
| 2026-05-05 | 8-K | 8-K | 2.02,9.01 | 0001724521-26-000032 | 001-38419 | 26943128 | 34 | 305010 | 1 | 1 |
| 2026-04-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003724 | 001-38419 | 26889345 | 33 | 5324 | |||
| 2026-04-21 | ARS | ARS | 0001724521-26-000027 | 001-38419 | 26879498 | 34 | 19938545 | |||
| 2026-04-21 | DEFA14A | DEFA14A | 0001724521-26-000026 | 001-38419 | 26879471 | 34 | 369838 | |||
| 2026-04-21 | DEF 14A | DEF 14A | 0001724521-26-000025 | 001-38419 | 26879455 | 34 | 2297316 | 1 | 1 | |
| 2026-04-20 | 8-K | 8-K | 8.01 | 0001724521-26-000021 | 001-38419 | 26873372 | 34 | 142427 | 1 | 1 |
| 2026-04-08 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003313 | 001-38419 | 26848373 | 33 | 4629 | |||
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-000680 | 005-90423 | 26797813 | 34 | 7070 | |||
| 2026-03-23 | 8-K | 8-K | 5.02 | 0001724521-26-000014 | 001-38419 | 26779919 | 34 | 138822 | 1 | 1 |
| 2026-02-25 | S-3ASR | S-3ASR | 0001193125-26-071862 | 333-293750 | 26679522 | 33 | 1245988 | 1 | 1 | |
| 2026-02-25 | S-8 | S-8 | 0001724521-26-000011 | 333-293740 | 26678949 | 33 | 279555 | 1 | 1 | |
| 2026-02-25 | 10-K | 10-K | 0001724521-26-000009 | 001-38419 | 26678659 | 34 | 11768914 | 1 | 1 | |
| 2026-02-25 | 8-K | 8-K | 2.02,9.01 | 0001724521-26-000007 | 001-38419 | 26678561 | 34 | 321268 | 1 | 1 |
| 2026-01-26 | 4 | FORM 4 | 0002056093-26-000002 | 7075 | ||||||
| 2026-01-26 | 4 | FORM 4 | 0001182473-26-000005 | 7098 | ||||||
| 2026-01-26 | 4 | FORM 4 | 0001422996-26-000004 | 7739 | ||||||
| 2026-01-26 | 4 | FORM 4 | 0001836662-26-000002 | 7059 | ||||||
| 2026-01-26 | 4 | FORM 4 | 0001653881-26-000002 | 7074 | ||||||
| 2026-01-26 | 4 | FORM 4 | 0001771961-26-000002 | 7090 | ||||||
| 2026-01-26 | 4 | FORM 4 | 0001671311-26-000002 | 7119 | ||||||
| 2026-01-09 | 4 | FORM 4 | 0001182473-26-000003 | 4751 | ||||||
| 2026-01-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000038 | 005-90423 | 26518855 | 34 | 10971 | |||
| 2026-01-07 | 4 | FORM 4 | 0001422996-26-000002 | 9579 | ||||||
| 2026-01-05 | 144 | xsl144X01/primary_doc.xml | 0001958244-26-000009 | 001-38419 | 26507405 | 33 | 11704 | |||
| 2026-01-02 | 4 | xslF345X05/form4.xml | 0001610717-26-000002 | 4379 | ||||||
| 2026-01-02 | 4 | xslF345X05/form4.xml | 0001610717-26-000001 | 4522 | ||||||
| 2025-12-31 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-059249 | 001-38419 | 251618290 | 33 | 6688 | |||
| 2025-12-18 | 4 | FORM 4 | 0001836662-25-000005 | 7760 | ||||||
| 2025-12-18 | 4 | FORM 4 | 0002056093-25-000005 | 7944 | ||||||
| 2025-12-18 | 4 | FORM 4 | 0001771961-25-000014 | 9757 | ||||||
| 2025-12-18 | 4 | FORM 4 | 0001653881-25-000011 | 7595 | ||||||
| 2025-12-18 | 4 | FORM 4 | 0001671311-25-000009 | 7639 | ||||||
| 2025-12-18 | 4 | FORM 4 | 0001422996-25-000015 | 8259 | ||||||
| 2025-12-18 | 4 | FORM 4 | 0001182473-25-000005 | 7844 | ||||||
| 2025-12-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010514 | 001-38419 | 251583384 | 33 | 6102 | |||
| 2025-12-18 | 8-K | 8-K | 1.01,2.03 | 0001724521-25-000122 | 001-38419 | 251583068 | 34 | 142791 | 1 | 1 |
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0002056093-25-000003 | 001-38419 | 251572854 | 33 | 4430 | |||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001836662-25-000003 | 001-38419 | 251572851 | 33 | 6157 | |||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001771961-25-000011 | 001-38419 | 251572849 | 33 | 7940 | |||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001653881-25-000009 | 001-38419 | 251572845 | 33 | 7351 | |||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001671311-25-000007 | 001-38419 | 251572841 | 33 | 7988 | |||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001422996-25-000013 | 001-38419 | 251572838 | 33 | 10526 | |||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001182473-25-000003 | 001-38419 | 251572835 | 33 | 6259 | |||
| 2025-12-12 | 8-K | 8-K | 8.01 | 0001724521-25-000120 | 001-38419 | 251566636 | 34 | 143683 | 1 | 1 |
| 2025-12-05 | 4 | FORM 4 | 0001422996-25-000011 | 5864 | ||||||
| 2025-12-04 | 144 | xsl144X01/primary_doc.xml | 0001958244-25-004517 | 001-38419 | 251550551 | 33 | 10098 | |||
| 2025-12-01 | 4 | FORM 4 | 0001771961-25-000009 | 8341 | ||||||
| 2025-11-26 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-009435 | 001-38419 | 251530560 | 33 | 6108 | |||
| 2025-11-26 | 4 | FORM 4 | 0001653881-25-000007 | 4654 | ||||||
| 2025-11-26 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-054135 | 001-38419 | 251529276 | 33 | 5450 | |||
| 2025-11-19 | 4 | FORM 4 | 0001422996-25-000009 | 9963 | ||||||
| 2025-11-17 | 144 | xsl144X01/primary_doc.xml | 0001958244-25-004463 | 001-38419 | 251492350 | 33 | 9183 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-005004 | 005-90423 | 251485995 | 34 | 12072 | |||
| 2025-11-12 | 4 | FORM 4 | 0001671311-25-000005 | 8804 | ||||||
| 2025-11-05 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001123292-25-000613 | 005-90423 | 251455176 | 34 | 9481 | |||
| 2025-11-03 | 4 | FORM 4 | 0001422996-25-000007 | 5865 | ||||||
| 2025-11-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-262589 | 001-38419 | 251444332 | 34 | 409694 | 1 | 1 |
| 2025-10-31 | 424B5 | 424B5 | 0001193125-25-260836 | 333-270132 | 251440833 | 33 | 953002 | 1 | 1 | |
| 2025-10-30 | 144 | xsl144X01/primary_doc.xml | 0001958244-25-004423 | 001-38419 | 251437420 | 33 | 8486 | |||
| 2025-10-30 | 424B5 | 424B5 | 0001193125-25-258794 | 333-270132 | 251436809 | 33 | 816751 | |||
| 2025-10-30 | 4 | FORM 4 | 0001422996-25-000005 | 12019 | ||||||
| 2025-10-29 | 4 | FORM 4 | 0001653881-25-000005 | 4671 | ||||||
| 2025-10-28 | 144/A | xsl144X01/primary_doc.xml | 0001628280-25-046879 | 001-38419 | 251426371 | 33 | 4475 | |||
| 2025-10-28 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-046836 | 001-38419 | 251425819 | 33 | 4213 | |||
| 2025-10-28 | 144 | xsl144X01/primary_doc.xml | 0001958244-25-004418 | 001-38419 | 251425774 | 33 | 5272 | |||
| 2025-10-28 | 10-Q | 10-Q | 0001724521-25-000116 | 001-38419 | 251424928 | 34 | 7188956 | 1 | 1 | |
| 2025-10-28 | 8-K | 8-K | 2.02,9.01 | 0001724521-25-000114 | 001-38419 | 251424866 | 34 | 330602 | 1 | 1 |
| 2025-10-14 | 8-K | 8-K | 8.01 | 0001724521-25-000109 | 001-38419 | 251389961 | 34 | 148622 | 1 | 1 |
| 2025-10-08 | 4 | FORM 4 | 0001671311-25-000003 | 14491 | ||||||
| 2025-10-06 | 144 | xsl144X01/primary_doc.xml | 0001968582-25-000981 | 001-38419 | 251377192 | 33 | 4495 | |||
| 2025-10-06 | 8-K | 8-K | 8.01 | 0001724521-25-000107 | 001-38419 | 251375948 | 34 | 191650 | 1 | 1 |
| 2025-09-30 | 4 | FORM 4 | 0001771961-25-000006 | 4686 | ||||||
| 2025-09-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007554 | 001-38419 | 251356686 | 33 | 5397 | |||
| 2025-09-05 | 4 | FORM 4 | 0001771961-25-000003 | 5394 | ||||||
| 2025-09-05 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-006799 | 001-38419 | 251297041 | 33 | 4695 | |||
| 2025-08-06 | 10-Q | 10-Q | 0001724521-25-000101 | 001-38419 | 251189735 | 34 | 7346869 | 1 | 1 | |
| 2025-08-06 | 8-K | 8-K | 2.02,9.01 | 0001724521-25-000099 | 001-38419 | 251189623 | 34 | 323295 | 1 | 1 |
| 2025-07-15 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001123292-25-000309 | 005-90423 | 251125981 | 34 | 10120 | |||
| 2025-06-12 | 4 | FORM 4 | 0001724521-25-000092 | 17433 | ||||||
| 2025-06-12 | 4 | FORM 4 | 0001724521-25-000091 | 18134 | ||||||
| 2025-06-12 | 4 | FORM 4 | 0001724521-25-000090 | 17325 | ||||||
| 2025-06-12 | 4 | FORM 4 | 0001724521-25-000089 | 18144 | ||||||
| 2025-06-12 | 4 | FORM 4 | 0001724521-25-000088 | 17423 | ||||||
| 2025-06-12 | 4 | FORM 4 | 0001724521-25-000087 | 19794 | ||||||
| 2025-06-12 | 4 | FORM 4 | 0001724521-25-000086 | 17429 | ||||||
| 2025-06-12 | 8-K | 8-K | 5.07,8.01,9.01 | 0001724521-25-000078 | 001-38419 | 251043001 | 34 | 178277 | 1 | 1 |
| 2025-06-02 | 8-K | 8-K | 7.01,8.01 | 0001724521-25-000066 | 001-38419 | 251013206 | 34 | 144761 | 1 | 1 |
| 2025-05-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-002303 | 005-90423 | 25941850 | 34 | 17012 | |||
| 2025-05-06 | 10-Q | 10-Q | 0001724521-25-000063 | 001-38419 | 25917390 | 34 | 7484815 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,9.01 | 0001724521-25-000061 | 001-38419 | 25917316 | 34 | 346154 | 1 | 1 |
| 2025-04-22 | ARS | ARS | 0001724521-25-000056 | 001-38419 | 25857882 | 34 | 19962512 | |||
| 2025-04-22 | DEFA14A | DEFA14A | 0001724521-25-000054 | 001-38419 | 25857847 | 34 | 371598 | |||
| 2025-04-22 | DEF 14A | DEF 14A | 0001724521-25-000052 | 001-38419 | 25857818 | 34 | 2492929 | 1 | 1 | |
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000558 | 005-90423 | 25844550 | 34 | 10963 | |||
| 2025-03-05 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001123292-25-000115 | 005-90423 | 25712220 | 34 | 75763 | |||
| 2025-02-27 | 4 | FORM 4 | 0001724521-25-000046 | 7261 | ||||||
| 2025-02-27 | 4 | FORM 4 | 0001724521-25-000045 | 5022 | ||||||
| 2025-02-25 | S-8 | S-8 | 0001724521-25-000042 | 333-285205 | 25663517 | 33 | 295479 | 1 | 1 | |
| 2025-02-25 | 10-K | 10-K | 0001724521-25-000040 | 001-38419 | 25663120 | 34 | 11874871 | 1 | 1 | |
| 2025-02-25 | 8-K | 8-K | 2.02,9.01 | 0001724521-25-000039 | 001-38419 | 25663070 | 34 | 366657 | 1 | 1 |
| 2025-02-20 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001123292-25-000105 | 005-90423 | 25648051 | 34 | 57988 | |||
| 2025-02-20 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-003084 | 4670 | ||||||
| 2025-02-19 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-029591 | 001-38419 | 25639903 | 34 | 449363 | 1 | 1 |
| 2025-02-18 | 424B5 | 424B5 | 0001193125-25-028669 | 333-270132 | 25635768 | 33 | 814719 | 1 | 1 | |
| 2025-02-18 | 8-K | 8-K | 2.02,8.01 | 0001193125-25-028110 | 001-38419 | 25632660 | 34 | 164435 | 1 | 1 |
| 2025-02-11 | 4 | FORM 4 | 0001724521-25-000032 | 6935 | ||||||
| 2025-02-11 | 3 | FORM 3 | 0001724521-25-000031 | 9059 | ||||||
| 2025-02-10 | 3 | FORM 3 | 0001724521-25-000026 | 9048 | ||||||
| 2025-02-06 | 8-K | 8-K | 5.02 | 0001724521-25-000024 | 001-38419 | 25598264 | 34 | 147376 | 1 | 1 |
| 2025-01-27 | 4 | FORM 4 | 0001724521-25-000021 | 6922 | ||||||
| 2025-01-27 | 4 | FORM 4 | 0001724521-25-000020 | 6959 | ||||||
| 2025-01-27 | 4 | FORM 4 | 0001724521-25-000019 | 6509 | ||||||
| 2025-01-27 | 4 | FORM 4 | 0001724521-25-000018 | 6979 | ||||||
| 2025-01-27 | 4 | FORM 4 | 0001724521-25-000017 | 6974 | ||||||
| 2025-01-27 | 4 | FORM 4 | 0001724521-25-000016 | 6950 | ||||||
| 2025-01-27 | 4 | FORM 4 | 0001724521-25-000015 | 5797 | ||||||
| 2025-01-27 | 4 | FORM 4 | 0001724521-25-000014 | 7600 | ||||||
| 2025-01-21 | 8-K | 8-K | 5.02 | 0001724521-25-000005 | 001-38419 | 25542620 | 34 | 147861 | 1 | 1 |
| 2025-01-03 | 4 | FORM 4 | 0001724521-25-000002 | 4825 | ||||||
| 2024-12-31 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000915 | 001-38419 | 241593115 | 33 | 4311 | |||
| 2024-12-20 | 4 | FORM 4 | 0001724521-24-000187 | 4696 | ||||||
| 2024-12-17 | SC 13D/A | SC 13D/A | 0001193125-24-280681 | 005-90423 | 241557476 | 34 | 32985 | |||
| 2024-12-17 | 4 | FORM 4 | 0001724521-24-000184 | 4817 | ||||||
| 2024-12-17 | 4 | FORM 4 | 0001724521-24-000183 | 4760 | ||||||
| 2024-12-17 | 4 | FORM 4 | 0001724521-24-000182 | 5217 | ||||||
| 2024-12-17 | 4 | FORM 4 | 0001724521-24-000181 | 4803 | ||||||
| 2024-12-17 | 4 | FORM 4 | 0001724521-24-000180 | 4812 | ||||||
| 2024-12-17 | 4 | FORM 4 | 0001724521-24-000179 | 4790 | ||||||
| 2024-12-17 | 4 | FORM 4 | 0001724521-24-000178 | 5438 | ||||||
| 2024-12-04 | 4 | FORM 4 | 0001724521-24-000162 | 4873 | ||||||
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002635 | 005-90423 | 241444420 | 34 | 8247 | |||
| 2024-11-08 | SC 13G/A | us03969f1093_110824.txt | 0002012383-24-004072 | 005-90423 | 241442091 | 34 | 13919 | |||
| 2024-11-06 | 10-Q | 10-Q | 0001724521-24-000160 | 001-38419 | 241431437 | 34 | 7978569 | 1 | 1 | |
| 2024-11-06 | 8-K | 8-K | 2.02,9.01 | 0001724521-24-000159 | 001-38419 | 241431407 | 34 | 366659 | 1 | 1 |
| 2024-10-24 | 8-K | 8-K | 7.01,8.01 | 0001724521-24-000153 | 001-38419 | 241392738 | 34 | 157345 | 1 | 1 |
| 2024-10-23 | SC 13G/A | us03969f1093_102324.txt | 0002012383-24-001809 | 005-90423 | 241389789 | 34 | 13907 | |||
| 2024-10-17 | SC 13G/A | Arcus_Biosciences_Inc.htm | 0000093751-24-000804 | 005-90423 | 241376486 | 34 | 55943 | |||
| 2024-09-17 | 4 | FORM 4 | 0001724521-24-000150 | 4817 | ||||||
| 2024-09-17 | 4 | FORM 4 | 0001724521-24-000149 | 4979 | ||||||
| 2024-08-27 | 8-K | 8-K | 1.01,2.03 | 0001724521-24-000144 | 001-38419 | 241249146 | 34 | 160531 | 1 | 1 |
| 2024-08-15 | 4 | FORM 4 | 0001724521-24-000141 | 4875 | ||||||
| 2024-08-08 | 10-Q | 10-Q | 0001724521-24-000138 | 001-38419 | 241188535 | 34 | 6749968 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0001724521-24-000136 | 001-38419 | 241188335 | 34 | 364655 | 1 | 1 |
| 2024-06-18 | 4 | FORM 4 | 0001724521-24-000129 | 4796 | ||||||
| 2024-06-18 | 4 | FORM 4 | 0001724521-24-000128 | 5437 | ||||||
| 2024-06-18 | 4 | FORM 4 | 0001724521-24-000127 | 4991 | ||||||
| 2024-06-18 | 4 | FORM 4 | 0001724521-24-000126 | 4933 | ||||||
| 2024-06-07 | 4 | FORM 4 | 0001724521-24-000116 | 9087 | ||||||
| 2024-06-07 | 4 | FORM 4 | 0001724521-24-000115 | 6999 | ||||||
| 2024-06-07 | 4 | FORM 4 | 0001724521-24-000114 | 7739 | ||||||
| 2024-06-07 | 4 | FORM 4 | 0001724521-24-000113 | 7108 | ||||||
| 2024-06-07 | 4 | FORM 4 | 0001724521-24-000112 | 6994 | ||||||
| 2024-06-07 | 4 | FORM 4 | 0001724521-24-000111 | 7711 | ||||||
| 2024-06-07 | 4 | FORM 4 | 0001724521-24-000110 | 7001 | ||||||
| 2024-06-06 | 8-K | 8-K | 5.07,8.01,9.01 | 0001724521-24-000101 | 001-38419 | 241025870 | 34 | 183615 | 1 | 1 |
| 2024-06-03 | 8-K | 8-K | 7.01,8.01 | 0001724521-24-000099 | 001-38419 | 241012067 | 34 | 169797 | 1 | 1 |
| 2024-05-23 | 8-K | 8-K | 8.01,9.01 | 0001724521-24-000096 | 001-38419 | 24979368 | 34 | 185901 | 1 | 1 |
| 2024-05-08 | 10-Q | 10-Q | 0001724521-24-000092 | 001-38419 | 24926034 | 34 | 6913827 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0001724521-24-000090 | 001-38419 | 24925810 | 34 | 344517 | 1 | 1 |
| 2024-04-24 | ARS | ARS | 0001724521-24-000083 | 001-38419 | 24866484 | 34 | 16443609 | |||
| 2024-04-23 | DEFA14A | DEFA14A | 0001724521-24-000081 | 001-38419 | 24864916 | 34 | 361402 | |||
| 2024-04-23 | DEF 14A | DEF 14A | 0001724521-24-000079 | 001-38419 | 24864891 | 34 | 2512580 | 1 | 1 | |
| 2024-03-29 | 4 | FORM 4 | 0001724521-24-000071 | 5251 | ||||||
| 2024-03-27 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-000263 | 001-38419 | 24790744 | 33 | 6915 | |||
| 2024-03-20 | 4 | FORM 4 | 0001724521-24-000068 | 7456 | ||||||
| 2024-03-15 | 144 | xsl144X01/primary_doc.xml | 0001724521-24-000065 | 001-38419 | 24755264 | 33 | 7615 | |||
| 2024-02-28 | 4 | FORM 4 | 0001724521-24-000063 | 7182 | ||||||
| 2024-02-28 | 4 | FORM 4 | 0001724521-24-000062 | 7917 | ||||||
| 2024-02-23 | 4/A | FORM 4/A | 0001724521-24-000057 | 4987 | ||||||
| 2024-02-21 | S-3ASR | S-3ASR | 0001193125-24-041550 | 333-277224 | 24660580 | 33 | 279012 | |||
| 2024-02-21 | S-8 | S-8 | 0001724521-24-000054 | 333-277219 | 24660164 | 33 | 139331 | |||
| 2024-02-21 | 10-K | 10-K | 0001724521-24-000052 | 001-38419 | 24659692 | 34 | 10836206 | 1 | 1 | |
| 2024-02-21 | 8-K | 8-K | 2.02,9.01 | 0001724521-24-000050 | 001-38419 | 24659465 | 34 | 368527 | 1 | 1 |
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020321 | 005-90423 | 24627382 | 34 | 12995 | |||
| 2024-02-09 | SC 13G | filing.txt | 0000315066-24-000970 | 005-90423 | 24611371 | 34 | 8068 | |||
| 2024-02-07 | 3 | FORM 3 | 0001724521-24-000038 | 8982 | ||||||
| 2024-01-31 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-008868 | 4893 | ||||||
| 2024-01-31 | SC 13D/A | SC 13D/A | 0001104659-24-008866 | 005-90423 | 24583755 | 34 | 470486 | |||
| 2024-01-30 | 8-K | 8-K | 1.01,3.02,5.02,8.01,9.01 | 0001724521-24-000034 | 001-38419 | 24575943 | 34 | 258813 | 1 | 1 |
| 2024-01-25 | 4 | FORM 4 | 0001724521-24-000030 | 6971 | ||||||
| 2024-01-25 | 4 | FORM 4 | 0001724521-24-000029 | 6913 | ||||||
| 2024-01-25 | 4 | FORM 4 | 0001724521-24-000028 | 6946 | ||||||
| 2024-01-25 | 4 | FORM 4 | 0001724521-24-000027 | 6922 | ||||||
| 2024-01-25 | 4 | FORM 4 | 0001724521-24-000026 | 6959 | ||||||
| 2024-01-25 | 4 | FORM 4 | 0001724521-24-000025 | 6979 | ||||||
| 2024-01-25 | 4 | FORM 4 | 0001724521-24-000024 | 6966 | ||||||
| 2024-01-24 | SC 13G | Arcus_Bioscience.txt | 0000093751-24-000108 | 005-90423 | 24554241 | 34 | 8442 | |||
| 2024-01-23 | SC 13G/A | us03969f1093_012324.txt | 0001086364-24-001338 | 005-90423 | 24551309 | 34 | 13617 | |||
| 2024-01-04 | 4 | FORM 4 | 0001724521-24-000009 | 4825 | ||||||
| 2024-01-04 | 4 | FORM 4 | 0001724521-24-000008 | 5874 | ||||||
| 2024-01-04 | 144/A | xsl144X01/primary_doc.xml | 0001958244-24-000015 | 001-38419 | 24512009 | 33 | 6831 | |||
| 2024-01-02 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000013 | 001-38419 | 24503722 | 33 | 4822 | |||
| 2024-01-02 | 4 | FORM 4 | 0001724521-24-000003 | 4475 | ||||||
| 2024-01-02 | 144 | xsl144X01/primary_doc.xml | 0001958244-24-000011 | 001-38419 | 24503501 | 33 | 5202 | |||
| 2023-12-26 | 4 | FORM 4 | 0001724521-23-000076 | 5252 | ||||||
| 2023-12-22 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000845 | 001-38419 | 231510093 | 33 | 7111 | |||
| 2023-12-22 | 4 | FORM 4 | 0001724521-23-000073 | 4694 | ||||||
| 2023-12-20 | 4 | FORM 4 | 0001724521-23-000070 | 7571 | ||||||
| 2023-12-20 | 4 | FORM 4 | 0001724521-23-000069 | 7617 | ||||||
| 2023-12-20 | 4 | FORM 4 | 0001724521-23-000068 | 7427 | ||||||
| 2023-12-20 | 4 | FORM 4 | 0001724521-23-000067 | 7450 | ||||||
| 2023-12-20 | 4 | FORM 4 | 0001724521-23-000066 | 7633 | ||||||
| 2023-12-20 | 4 | FORM 4 | 0001724521-23-000065 | 8077 | ||||||
| 2023-12-20 | 4 | FORM 4 | 0001724521-23-000064 | 7438 | ||||||
| 2023-12-15 | 144 | xsl144X01/primary_doc.xml | 0001724521-23-000042 | 001-38419 | 231490668 | 33 | 5504 | |||
| 2023-12-15 | 144 | xsl144X01/primary_doc.xml | 0001724521-23-000040 | 001-38419 | 231490641 | 33 | 4985 | |||
| 2023-12-15 | 144 | xsl144X01/primary_doc.xml | 0001724521-23-000038 | 001-38419 | 231490609 | 33 | 5561 | |||
| 2023-12-15 | 144 | xsl144X01/primary_doc.xml | 0001724521-23-000036 | 001-38419 | 231490587 | 33 | 6876 | |||
| 2023-12-15 | 144 | xsl144X01/primary_doc.xml | 0001724521-23-000034 | 001-38419 | 231490552 | 33 | 5562 | |||
| 2023-12-15 | 144 | xsl144X01/primary_doc.xml | 0001724521-23-000032 | 001-38419 | 231490508 | 33 | 5598 | |||
| 2023-12-05 | 4 | FORM 4 | 0001724521-23-000024 | 4793 | ||||||
| 2023-11-07 | 10-Q | 10-Q | 0001724521-23-000021 | 001-38419 | 231384040 | 34 | 6626620 | 1 | 1 | |
| 2023-11-07 | 8-K | 8-K | 2.02,9.01 | 0001724521-23-000018 | 001-38419 | 231383612 | 34 | 362880 | 1 | 1 |
| 2023-09-26 | 4 | FORM 4 | 0001724521-23-000011 | 5170 | ||||||
| 2023-09-22 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000533 | 001-38419 | 231271901 | 33 | 8164 | |||
| 2023-09-20 | 4 | FORM 4 | 0001724521-23-000008 | 5081 | ||||||
| 2023-09-20 | 4 | FORM 4 | 0001724521-23-000006 | 4921 | ||||||
| 2023-09-15 | 144 | xsl144X01/primary_doc.xml | 0001628280-23-032390 | 001-38419 | 231259299 | 33 | 4386 | |||
| 2023-09-15 | 144 | xsl144X01/primary_doc.xml | 0001628280-23-032387 | 001-38419 | 231259270 | 33 | 6361 | |||
| 2023-08-07 | 10-Q | 10-Q | 0000950170-23-038760 | 001-38419 | 231145729 | 34 | 9615693 | 1 | 1 | |
| 2023-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-038757 | 001-38419 | 231145720 | 34 | 604991 | 1 | 1 |
| 2023-07-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-043821 | 5286 | ||||||
| 2023-07-06 | SC 13D/A | SC 13D/A | 0001104659-23-078512 | 005-90423 | 231072276 | 34 | 274747 | |||
| 2023-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-040964 | 4732 | ||||||
| 2023-06-30 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-077015 | 4796 | ||||||
| 2023-06-28 | 8-K | 8-K | 1.01,3.02 | 0000950170-23-030273 | 001-38419 | 231049315 | 34 | 162351 | 1 | 1 |
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039718 | 5286 | ||||||
| 2023-06-22 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000275 | 001-38419 | 231033395 | 33 | 5933 | |||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038160 | 5678 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038157 | 5735 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038154 | 7901 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038152 | 5737 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038150 | 7236 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038148 | 7211 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038145 | 7243 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038144 | 7955 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038142 | 7352 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038141 | 9575 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-038139 | 9616 | ||||||
| 2023-06-16 | 8-K | 8-K | 5.07,8.01,9.01 | 0000950170-23-028621 | 001-38419 | 231021422 | 34 | 234176 | 1 | 1 |
| 2023-06-15 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-028297 | 001-38419 | 231017605 | 33 | 4221 | |||
| 2023-06-15 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-028296 | 001-38419 | 231017590 | 33 | 4957 | |||
| 2023-06-15 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-028292 | 001-38419 | 231017530 | 33 | 4271 | |||
| 2023-06-15 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-028286 | 001-38419 | 231017462 | 33 | 4304 | |||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-035740 | 5276 | ||||||
| 2023-06-07 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000220 | 001-38419 | 23998583 | 33 | 4717 | |||
| 2023-06-05 | 8-K | 8-K | 7.01,8.01 | 0000950170-23-026241 | 001-38419 | 23991303 | 34 | 216964 | 1 | 1 |
| 2023-05-15 | 8-K | 8-K | 1.01 | 0000950170-23-021988 | 001-38419 | 23918630 | 34 | 161388 | 1 | 1 |
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019695 | 001-38419 | 23902224 | 34 | 8008101 | 1 | 1 | |
| 2023-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-019659 | 001-38419 | 23902058 | 34 | 499618 | 1 | 1 |
| 2023-04-25 | ARS | ARS | 0000950170-23-014445 | 001-38419 | 23845160 | 34 | 1209080 | |||
| 2023-04-21 | DEFA14A | DEFA14A | 0000950170-23-013844 | 001-38419 | 23836492 | 34 | 373756 | |||
| 2023-04-21 | DEF 14A | DEF 14A | 0000950170-23-013840 | 001-38419 | 23836438 | 34 | 4037894 | 1 | 1 | |
| 2023-03-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-020037 | 5565 | ||||||
| 2023-03-10 | 3 | FORM 3 SUBMISSION | 0001209191-23-017833 | 15242 | ||||||
| 2023-03-10 | 8-K | 8-K | 5.02 | 0000950170-23-007320 | 001-38419 | 23724355 | 34 | 164313 | 1 | 1 |
| 2023-02-28 | S-3ASR | S-3ASR | 0001193125-23-054100 | 333-270132 | 23687016 | 33 | 1089110 | |||
| 2023-02-28 | S-8 | S-8 | 0000950170-23-005155 | 333-270114 | 23686223 | 33 | 286428 | |||
| 2023-02-28 | 10-K | 10-K | 0000950170-23-005112 | 001-38419 | 23685664 | 34 | 16195452 | 1 | 1 | |
| 2023-02-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-005084 | 001-38419 | 23685332 | 34 | 617316 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021577 | 005-90423 | 23628972 | 34 | 108839 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-23-000534 | 005-90423 | 23625145 | 34 | 276853 | |||
| 2023-02-10 | SC 13G/A | rcus13ga.htm | 0000935836-23-000088 | 005-90423 | 23607585 | 34 | 46861 | |||
| 2023-02-09 | SC 13G | SCHEDULE 13G | 0001104659-23-015346 | 005-90423 | 23602446 | 34 | 12884 | |||
| 2023-01-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-005513 | 7313 | ||||||
| 2023-01-26 | SC 13G/A | us03969f1093_012623.txt | 0001306550-23-004065 | 005-90423 | 23554242 | 34 | 13206 | |||
| 2023-01-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-004876 | 7149 | ||||||
| 2023-01-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-004875 | 7184 | ||||||
| 2023-01-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-004874 | 7131 | ||||||
| 2023-01-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-004873 | 7189 | ||||||
| 2023-01-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-004872 | 7810 | ||||||
| 2023-01-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-004870 | 7872 | ||||||
| 2023-01-20 | SC 13G/A | us03969f1093_011923.txt | 0001306550-23-000622 | 005-90423 | 23539216 | 34 | 13182 | |||
| 2022-12-19 | 8-K | 8-K | 8.01 | 0000950170-22-026760 | 001-38419 | 221471913 | 34 | 186453 | 1 | 1 |
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-061762 | 7618 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-061761 | 7565 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-061760 | 7801 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-061759 | 8245 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-061758 | 8308 | ||||||
| 2022-11-28 | 8-K | 8-K | 8.01 | 0000950170-22-025712 | 001-38419 | 221421174 | 34 | 161670 | 1 | 1 |
| 2022-11-02 | 10-Q | 10-Q | 0000950170-22-021241 | 001-38419 | 221354188 | 34 | 10611466 | 1 | 1 | |
| 2022-11-02 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-021219 | 001-38419 | 221353970 | 34 | 585705 | 1 | 1 |
| 2022-10-17 | SC 13G | SC 13G | 0001104659-22-109315 | 005-90423 | 221313791 | 34 | 125880 | |||
| 2022-10-11 | S-3ASR | S-3ASR | 0001193125-22-260690 | 333-267822 | 221304584 | 33 | 270932 | |||
| 2022-10-11 | 8-K | 8-K | 1.01,9.01 | 0001193125-22-260620 | 001-38419 | 221304214 | 34 | 154141 | 1 | 1 |
| 2022-09-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-050704 | 5535 | ||||||
| 2022-08-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-047316 | 7145 | ||||||
| 2022-08-08 | 3 | FORM 3 SUBMISSION | 0001209191-22-044783 | 5954 | ||||||
| 2022-08-03 | 10-Q | 10-Q | 0000950170-22-014280 | 001-38419 | 221132971 | 34 | 9643762 | 1 | 1 | |
| 2022-08-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-014263 | 001-38419 | 221132833 | 34 | 572367 | 1 | 1 |
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-038399 | 9830 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-038396 | 10398 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-038390 | 9889 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-038386 | 10336 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037443 | 8101 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037438 | 7403 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037417 | 7498 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037414 | 7203 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037412 | 7389 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037409 | 9542 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037408 | 8125 | ||||||
| 2022-06-16 | 8-K | 8-K | 5.07,8.01,9.01 | 0000950170-22-011747 | 001-38419 | 221020728 | 34 | 258294 | 1 | 1 |
| 2022-06-07 | UPLOAD | filename1.pdf | 0000000000-22-006159 | 39438 | ||||||
| 2022-06-03 | CORRESP | filename1.htm | 0000950170-22-011156 | 92368 | ||||||
| 2022-05-10 | UPLOAD | filename1.pdf | 0000000000-22-005134 | 44265 | ||||||
| 2022-05-09 | 10-Q | 10-Q | 0000950170-22-008502 | 001-38419 | 22905138 | 34 | 8333751 | 1 | 1 | |
| 2022-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-008484 | 001-38419 | 22904950 | 34 | 487355 | 1 | 1 |
| 2022-05-09 | SC 13G | us03969f1093_050922.txt | 0000834237-22-009648 | 005-90423 | 22904540 | 34 | 13339 | |||
| 2022-04-20 | DEFA14A | DEFA14A | 0000950170-22-005859 | 001-38419 | 22838210 | 34 | 236699 | |||
| 2022-04-20 | DEF 14A | DEF 14A | 0000950170-22-005855 | 001-38419 | 22838161 | 34 | 1993798 | |||
| 2022-03-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-020038 | 5009 | ||||||
| 2022-03-14 | SC 13G | THE SCHEDULE 13G | 0000921895-22-000856 | 005-90423 | 22737247 | 34 | 285182 | |||
| 2022-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-017989 | 7123 | ||||||
| 2022-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-017984 | 7176 | ||||||
| 2022-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-017979 | 7184 | ||||||
| 2022-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-017973 | 7805 | ||||||
| 2022-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-017967 | 10216 | ||||||
| 2022-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-014850 | 5308 | ||||||
| 2022-02-23 | S-8 | S-8 | 0001564590-22-006304 | 333-262929 | 22664582 | 33 | 247983 | |||
| 2022-02-23 | 10-K | 10-K | 0000950170-22-001788 | 001-38419 | 22663890 | 34 | 15584320 | 1 | 1 | |
| 2022-02-23 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-001777 | 001-38419 | 22663595 | 34 | 543580 | 1 | 1 |
| 2022-02-14 | SC 13G/A | arcusbiosciences13ga.htm | 0000935836-22-000173 | 005-90423 | 22631183 | 34 | 47194 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-022225 | 005-90423 | 22628204 | 34 | 114442 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001193125-22-040721 | 005-90423 | 22628115 | 34 | 196584 | |||
| 2022-02-04 | SC 13G | us03969f1093_020422.txt | 0000834237-22-007136 | 005-90423 | 22593342 | 34 | 13368 | |||
| 2021-12-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-070958 | 9408 | ||||||
| 2021-12-21 | 8-K | 8-K | 8.01 | 0000950170-21-005305 | 001-38419 | 211509936 | 34 | 156462 | 1 | 1 |
| 2021-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-070568 | 16105 | ||||||
| 2021-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-070565 | 15978 | ||||||
| 2021-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-070563 | 16616 | ||||||
| 2021-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-070560 | 16176 | ||||||
| 2021-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-070557 | 17376 | ||||||
| 2021-11-18 | 8-K | 8-K | 1.01 | 0000950170-21-004749 | 001-38419 | 211422590 | 34 | 161770 | 1 | 1 |
| 2021-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-003506 | 001-38419 | 211388870 | 34 | 544303 | 1 | 1 |
| 2021-11-08 | 10-Q | 10-Q | 0000950170-21-003471 | 001-38419 | 211388186 | 34 | 9327658 | 1 | 1 | |
| 2021-09-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-057262 | 13518 | ||||||
| 2021-08-13 | 3 | FORM 3 SUBMISSION | 0001209191-21-051435 | 5916 | ||||||
| 2021-08-11 | 8-K | 8-K | 5.02 | 0001564590-21-043472 | 001-38419 | 211163900 | 34 | 155921 | 1 | 1 |
| 2021-08-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-049938 | 7111 | ||||||
| 2021-08-05 | 3 | FORM 3 SUBMISSION | 0001209191-21-049934 | 5894 | ||||||
| 2021-08-05 | 10-Q | 10-Q | 0001564590-21-041611 | 001-38419 | 211148501 | 34 | 8314797 | 1 | 1 | |
| 2021-08-05 | 8-K | 8-K | 2.02,5.02,9.01 | 0001564590-21-041591 | 001-38419 | 211148324 | 34 | 467452 | 1 | 1 |
| 2021-07-19 | SC 13G | arcus13g.htm | 0000935836-21-000427 | 005-90423 | 211098640 | 34 | 46835 | |||
| 2021-07-19 | 8-K | 8-K | 5.02,7.01,9.01 | 0001564590-21-037042 | 001-38419 | 211098378 | 34 | 178244 | 1 | 1 |
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042082 | 9830 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042080 | 11095 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042077 | 9716 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042075 | 10336 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042074 | 9900 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038651 | 5184 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038639 | 8144 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038635 | 7216 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038628 | 7540 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038623 | 7253 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038619 | 9788 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038616 | 8171 | ||||||
| 2021-06-07 | 8-K | 8-K | 5.07,8.01,9.01 | 0001564590-21-031965 | 001-38419 | 21999827 | 34 | 219508 | 1 | 1 |
| 2021-05-05 | 10-Q | 10-Q | 0001564590-21-024084 | 001-38419 | 21893602 | 34 | 7213997 | 1 | 1 | |
| 2021-05-05 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-024065 | 001-38419 | 21893390 | 34 | 382711 | 1 | 1 |
| 2021-04-26 | 8-K | 8-K | 7.01 | 0001564590-21-020541 | 001-38419 | 21854144 | 34 | 156033 | 1 | 1 |
| 2021-04-26 | 4 | FORM 4 - | 0001179110-21-004605 | 7069 | ||||||
| 2021-04-26 | 4 | FORM 4 - | 0001179110-21-004603 | 4806 | ||||||
| 2021-04-20 | DEFA14A | DEFA14A | 0001564590-21-019634 | 001-38419 | 21837987 | 34 | 1239380 | |||
| 2021-04-20 | DEF 14A | DEF 14A | 0001564590-21-019630 | 001-38419 | 21837942 | 34 | 1836622 | |||
| 2021-04-19 | 8-K | 8-K | 3.01 | 0001564590-21-019230 | 001-38419 | 21832680 | 34 | 155630 | 1 | 1 |
| 2021-04-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-024405 | 5673 |
One latest value per concept from companyfacts (304 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 143.99M | 2026-10-29 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 565.88M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 6.04M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-21 | 0001724521-26-000025 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 3.55M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-21 | 0001724521-26-000025 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 87.6 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-21 | 0001724521-26-000025 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 17.73M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-21 | 0001724521-26-000025 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 9.66M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-21 | 0001724521-26-000025 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 89.87 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-21 | 0001724521-26-000025 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 25,012.5 | 2026-10-21 | 424B5 | 2026-10-22 | 0001193125-26-428916 | |||
| ffd | NrrtvMaxAggtOfferingPric | NrrtvMaxAggtOfferingPric | USD | 287.50M | 2026-10-21 | 424B5 | 2026-10-22 | 0001193125-26-428916 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 25,012.5 | 2026-10-21 | 424B5 | 2026-10-22 | 0001193125-26-428916 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 287.50M | 2026-10-21 | 424B5 | 2026-10-22 | 0001193125-26-428916 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-21 | 424B5 | 2026-10-22 | 0001193125-26-428916 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-10-21 | 424B5 | 2026-10-22 | 0001193125-26-428916 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 44.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AccountsReceivableRelatedPartiesCurrent | Accounts Receivable, Related Parties, Current | USD | 32.00M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-07 | 0000950170-23-038760 | |
| us-gaap | AccountsReceivableRelatedPartiesNoncurrent | Accounts Receivable, Related Parties, Noncurrent | USD | 1.86M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 7.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 3.00M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001724521-23-000021 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 20.53M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 457,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 50.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -2.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.18B | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 16.00M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 21.63M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 50.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 21.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | AreaOfLand | Area of Land | sqft | 14,500 | 2022-04-30 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005112 | |
| us-gaap | Assets | Assets | USD | 818.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 664.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 694.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 2.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 696.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 743.37M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003471 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 62,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003471 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 154,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003471 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 743.46M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003471 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 345.21M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003471 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 694.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 479.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 64.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainLossNet | Available-for-sale Securities, Gross Realized Gain (Loss) | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003471 |
| us-gaap | AvailableForSaleSecuritiesNoncurrent | Available-for-sale Securities, Noncurrent | USD | 218.73M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003471 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | CapitalizedContractCostAmortization | Capitalized Contract Cost, Amortization | USD | 2.00M | 2024-01-01 | 2024-03-31 | 2025 | Q1 | 10-Q | 2025-05-06 | 0001724521-25-000063 |
| us-gaap | CapitalLeasesFutureMinimumSubleaseRentals | Capital Leases, Future Minimum Sublease Rentals | USD | 100,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 151.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 151.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -27.36M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 154.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -71.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 8.31M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 400.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 127.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 127.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2.19B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -349.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | ContractWithCustomerAssetNet | Contract with Customer, Asset, after Allowance for Credit Loss | USD | 3.00M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-06 | 0001724521-25-000063 | |
| us-gaap | ContractWithCustomerAssetNetCurrent | Contract with Customer, Asset, after Allowance for Credit Loss, Current | USD | 18.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 48.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 14.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 34.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 61.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | CostsAndExpensesRelatedParty | Costs and Expenses, Related Party | USD | 3.76M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | CurrentFederalStateAndLocalTaxExpenseBenefit | Current Federal, State and Local, Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 100.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | DebtInstrumentInterestRateEffectivePercentage | Debt Instrument, Interest Rate, Effective Percentage | pure | 0.13 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | -2.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 0 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-02 | 0001564590-19-015333 |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 300,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | position | 128 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 13.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 3.60M | 2018-03-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 3.73M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 7.00M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 12.02M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 | |
| us-gaap | DeferredRevenueRevenueRecognized1 | Deferred Revenue, Revenue Recognized | USD | 142.00M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0001724521-24-000092 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 19.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 425.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 39.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 7.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 59.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 26.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 412.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 4.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 1 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 7.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 2.70M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001564590-18-028583 |
| us-gaap | Dividends | Dividends | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 |
| us-gaap | DueFromRelatedPartiesCurrent | Due from Related Parties, Current | USD | 83,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.74 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.88 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-03 | 0000950170-22-014280 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.74 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.261 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -0.163 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 |
| us-gaap | EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary | Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent | pure | -0.041 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001724521-25-000040 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.009 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.014 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0.031 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.011 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.042 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 28.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 23.70M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 | |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 1.20M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 | |
| us-gaap | EquitySecuritiesFvNiRealizedGainLoss | Equity Securities, FV-NI, Realized Gain (Loss) | USD | 613,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041611 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041611 | |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041611 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041611 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041611 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041611 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041611 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041611 |
| us-gaap | GainLossOnSaleOfEquityInvestments | Gain (Loss) on Sale of Equity Investments | USD | 613,000 | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003471 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 76.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -353.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -347.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | USD/shares | -1.88 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-03 | 0000950170-22-014280 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -4.15 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0001724521-24-000052 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -4.15 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0001724521-24-000052 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | -613,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 92.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -74.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 5.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 4.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 15.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 2.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 2.48M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001564590-20-051355 |
| us-gaap | IncreaseDecreaseInContractWithCustomerAsset | Increase (Decrease) in Contract with Customer, Asset | USD | -23.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -63.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -2.00M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 |
| us-gaap | IncreaseDecreaseInDueFromRelatedPartiesCurrent | Increase (Decrease) in Due from Related Parties, Current | USD | -83,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | -4.13M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | 57,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | -20.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 2.15M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 |
| us-gaap | IncrementalCommonSharesAttributableToContingentlyIssuableShares | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares | shares | 7,588 | 2020-07-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003471 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001724521-26-000044 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 10.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 9.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 7.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 5.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | InvestmentsAndCash | Investments and Cash | USD | 694.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 116.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 22.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 18.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 20.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 19.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 19.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 18.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 1.16M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003471 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 17.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | Liabilities | Liabilities | USD | 695.12M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 818.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 199.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | LicenseAndServicesRevenue | License and Services Revenue (Deprecated 2018-01-31) | USD | 1.25M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001564590-18-012447 |
| us-gaap | LongTermDebt | Long-term Debt | USD | 102.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 26.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 129.43M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001564590-18-012447 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 248.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -16.49M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001564590-18-012447 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -345.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -347.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 14.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 428.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -361.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 17.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 99.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 14.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 86.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.47M | 2021-04-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008502 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 58.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 6.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 90.30M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 2.10M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 2.42M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 2.34M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 2.27M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 2.19M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 1.60M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.052 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 253.30M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 24.18M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 57.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -1.00M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -2.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 141.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 125.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 177,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | 3.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | OtherSundryLiabilitiesCurrent | Other Sundry Liabilities, Current | USD | 11.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001724521-25-000040 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 94,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 135,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0001724521-24-000052 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 1.09B | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 463.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001724521-23-000021 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001724521-23-000021 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 16.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 125.11M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 26.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 490.86M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 |
| us-gaap | ProceedsFromSaleOfShortTermInvestments | Proceeds from Sale of Short-term Investments | USD | 1.00M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -347.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 90.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 33.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | ProvisionForLoanLossesExpensed | Financing Receivable, Credit Loss, Expense (Reversal) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax | USD | 0 | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 352.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 3.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.83B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer | Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer | USD | 24.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 43.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 15.42M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041611 |
| us-gaap | RevenueRemainingPerformanceObligation | Revenue, Remaining Performance Obligation, Amount | USD | 256.00M | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | Revenues | Revenues | USD | 67.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001724521-25-000040 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 150.00M | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 13.60M | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 11 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | SecurityDeposit | Security Deposit | USD | 3.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 50.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 372,774 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 3.80M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 77.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 12.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 20.24 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 4.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 1.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 22.27 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 3.39M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040421 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 3.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 22.05 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 118.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 16.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 18.79 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 118.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 16.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 18.79 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 48.00M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-005112 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 37,250 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 11.6 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 12.75 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 300,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 358.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.253 | 2018-03-07 | 2018-03-09 | 2019 | FY | 10-K | 2020-03-05 | 0001564590-20-008972 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensation | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | shares | 713,931 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001564590-18-028583 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 400,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 226.20M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 2.30M | 2022-04-01 | 2022-06-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0000950170-22-021241 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 142.00M | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 188,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-23 | 0000950170-22-001788 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 100,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008270 |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 1.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 | |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 226.72M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006274 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 24.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 5.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 96.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-25 | 0001724521-26-000009 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 126.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 71.51M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-03 | 0000950170-22-014280 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-21 | 0001724521-24-000052 |
| us-gaap | WeightedAverageNumberOfSharesIssuedBasic | Weighted Average Number of Shares Issued, Basic | shares | 125.70M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001724521-26-000044 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 126.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001724521-26-000058 |